Director of Acumen Pharmaceuticals sold company shares, disclosed in a filing with the SEC.
2 reports, 2 independent
Updated Jun 17
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Director of Acumen Pharmaceuticals sold company shares, disclosed in a filing with the SEC.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Acumen Pharma filings with SEC regarding director stock trade while listed on Nasdaq.1 source
Director sold shares of Acumen Pharmaceuticals, disclosed to the SEC.1 source
Keep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- TransMedics Group, Inc. filed disclosures with the SEC and its stock began trading on the Nasdaq exchange.
- Rapport Therapeutics disclosed a stock sale in an SEC filing and is listed on Nasdaq.
- Odyssey Therapeutics, Inc. shares are being traded on the Nasdaq exchange.
- A company involved in insider transactions and increased investment stakes disclosed filings to the SEC.
- HCW Biologics Inc. filed disclosures with the SEC and its shares are listed on Nasdaq.